scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1005933397 |
P356 | DOI | 10.1007/S11684-015-0408-9 |
P698 | PubMed publication ID | 26276037 |
P50 | author | Daniel Wai Hung Ho | Q64617496 |
Irene Oi-lin Ng | Q67487913 | ||
P2093 | author name string | Alan Ka-Lun Kai | |
P2860 | cites work | Tumor-induced perturbations of cytokines and immune cell networks | Q27021807 |
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
Clinical importance of the cytochromes P450 | Q28208454 | ||
An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma | Q28237169 | ||
Gene expression profiling of liver cancer stem cells by RNA-sequencing | Q28483663 | ||
Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization | Q28511231 | ||
Hepatocellular carcinoma | Q29615765 | ||
Towards a knowledge-based Human Protein Atlas | Q29617987 | ||
Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker | Q31113966 | ||
Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity | Q33951756 | ||
RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma | Q34063655 | ||
CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway | Q34115620 | ||
Cytokine patterns in patients with cancer: a systematic review. | Q34342581 | ||
Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer | Q34680677 | ||
uGPA: unified Gene Pathway Analyzer package for high-throughput genome-wide screening data provides mechanistic overview on human diseases. | Q35535962 | ||
Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation | Q36499129 | ||
Comparative and integrative functional genomics of HCC. | Q36519015 | ||
Separate enrichment analysis of pathways for up- and downregulated genes. | Q37507799 | ||
Cytokine release from innate immune cells: association with diverse membrane trafficking pathways | Q37874392 | ||
Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning. | Q38176242 | ||
Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma | Q38304400 | ||
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy | Q38995507 | ||
Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing | Q39076259 | ||
Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2. | Q39987304 | ||
Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). | Q40453377 | ||
Xenobiotic-inducible transcription of cytochrome P450 genes. | Q40456814 | ||
Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control | Q41239155 | ||
Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions | Q59382361 | ||
P433 | issue | 3 | |
P921 | main subject | transcriptome | Q252857 |
hepatocellular carcinoma | Q1148337 | ||
P304 | page(s) | 322-330 | |
P577 | publication date | 2015-08-14 | |
P1433 | published in | Frontiers of medicine | Q26867043 |
P1476 | title | TCGA whole-transcriptome sequencing data reveals significantly dysregulated genes and signaling pathways in hepatocellular carcinoma | |
P478 | volume | 9 |
Q36084511 | Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages |
Q64109437 | Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma |
Q61449008 | Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma |
Q53708414 | Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway. |
Q52579808 | Current Challenges and Opportunities in Treating Glioblastoma. |
Q55122627 | Datasets describing the growth and molecular features of hepatocellular carcinoma patient-derived xenograft cells grown in a three-dimensional macroporous hydrogel. |
Q92382500 | Definition of a novel vascular invasion-associated multi-gene signature for predicting survival in patients with hepatocellular carcinoma |
Q55107289 | Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis. |
Q93149494 | Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers |
Q50190148 | Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient |
Q38853181 | Enhancing identification of cancer types via lowly-expressed microRNAs |
Q36313998 | From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma |
Q41056051 | Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq |
Q64933154 | Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma. |
Q31117540 | Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma |
Q89909200 | Integrative module analysis of HCC gene expression landscapes |
Q37212003 | Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma |
Q41544729 | Molecular Pathogenesis of Hepatocellular Carcinoma. |
Q91659743 | Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma |
Q64905840 | Precision oncology in liver cancer. |
Q37701656 | Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples |
Q92756927 | SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation |
Q36874692 | Successful establishment of patient-derived tumor xenografts from gastrointestinal stromal tumor-a single center experience |
Q47132322 | The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma. |
Q90114450 | The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis |
Q47149216 | The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics |
Q92067933 | The role of the CDCA gene family in ovarian cancer |
Q41093037 | Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma |
Q40493822 | Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis. |
Q47577021 | Virtual Sorting Has a Distinctive Advantage in Identification of Anticorrelated Genes and Further Negative Regulators of Immune Cell Subpopulations. |
Q96304077 | Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma |
Search more.